DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.

Author(s): Iravani A

Affiliation(s): Pediatric Nephrology, College of Medicine, University of Florida, Gainesville 32610-0296.

Publication date & source: 1991-09, Antimicrob Agents Chemother., 35(9):1940-2.

Publication type: Clinical Trial; Controlled Clinical Trial

A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017